A detailed history of Clarus Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Clarus Group, Inc. holds 8,314 shares of PFE stock, worth $246,593. This represents 0.1% of its overall portfolio holdings.

Number of Shares
8,314
Previous 18,588 55.27%
Holding current value
$246,593
Previous $515,000 54.95%
% of portfolio
0.1%
Previous 0.36%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$25.26 - $29.6 $259,521 - $304,110
-10,274 Reduced 55.27%
8,314 $232,000
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $11,029 - $12,664
426 Added 2.35%
18,588 $515,000
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $2,038 - $2,647
-78 Reduced 0.43%
18,162 $522,000
Q3 2023

Oct 16, 2023

SELL
$32.09 - $37.51 $16,879 - $19,730
-526 Reduced 2.8%
18,240 $605,000
Q2 2023

Jul 17, 2023

BUY
$36.12 - $41.79 $59,272 - $68,577
1,641 Added 9.58%
18,766 $688,000
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $590 - $769
15 Added 0.09%
17,125 $698,000
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $501 - $654
12 Added 0.07%
17,110 $0
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $12,559 - $15,331
-287 Reduced 1.65%
17,098 $748,000
Q2 2022

Jul 27, 2022

SELL
$46.53 - $55.17 $13,400 - $15,888
-288 Reduced 1.63%
17,385 $911,000
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $255,285 - $316,330
-5,580 Reduced 24.0%
17,673 $915,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $510 - $655
13 Added 0.06%
23,253 $1 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $42,732 - $48,409
-1,190 Reduced 4.87%
23,240 $921,000
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $818,160 - $922,721
24,430 New
24,430 $877,000
Q1 2021

Apr 16, 2021

SELL
$33.49 - $37.77 $817,591 - $922,079
-24,413 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $817,103 - $1.04 Million
24,413 New
24,413 $848,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Clarus Group, Inc. Portfolio

Follow Clarus Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarus Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clarus Group, Inc. with notifications on news.